Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
Limitation of Liability The publisher, authors, distributors, and affiliated parties disclaim all liability for any adverse outcomes, health consequences, financial losses, or other damages arising from use of information contained in this publication
Oikos has taken protein into a more community-driven space with the expansion of its Nutrition Sponsorship Program
Free shipping on purchases over 60 Direct contact You can contact the delivery company directly or write to our Customer Service team so that we can assist you
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel
While we could not measure any changes in receptor conformational shift following exendin-4 binding between GLP-1R WT and V229A (Supplementary Figure 2B, C), quantification of GLP-1R plasma membrane diffusion coefficients using RICS in INS-1 832/3 SNAP/FLAG-hGLP-1R WT versus V229A cells revealed a pronounced reduction in GLP-1R V229A plasma membrane diffusion compared to WT GLP-1R under vehicle conditions (Figure 4A, B), to a similar extent to the reduction caused by exendin-4 binding to GLP-1R WT, as observed here and previously (33), and recapitulating the effect triggered by reduced cholesterol levels following simvastatin exposure (Supplementary Figure 1C, D)
